Internal Medicine, Gastroenterology · Orange, CA
NPI
1750358735
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1010 W la Veta Ave, Suite 570
Orange, CA, 92868
Phone (714) 835-7700
Groups this clinician bills Medicare through
Medicare paid, 2024
$190K
3,085 services
Medicare patients, 2024
534
Average age 74
Drug cost, 2024
$671K
3,488 prescriptions
Company payments, 2025
$2,769
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James J Lee was code 99439 (chronic, principal, and transitional care management), 1,047 times for 90 patients. In total James J Lee billed 3,085 services in 44 codes, and Medicare paid $190K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,047 | 90 | $40.48 | $42K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 593 | 90 | $51.99 | $31K |
| 99213 Office E&M - Established | Office | 380 | 248 | $69.72 | $26K |
| 45385 Colonoscopy - Lesion Removal | Facility | 146 | 143 | $191.57 | $28K |
| 43239 Upper GI Endoscopy | Facility | 132 | 127 | $61.51 | $8,119 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 117 | 88 | $13.34 | $1,561 |
| 99203 Office E&M - New | Office | 102 | 102 | $79.21 | $8,079 |
| 45380 Lower GI Endoscopy - Other | Facility | 101 | 101 | $99.14 | $10K |
| 99454 E&M - Miscellaneous | Office | 76 | 14 | $43.63 | $3,316 |
| 99202 Office E&M - New | Office | 65 | 65 | $44.21 | $2,874 |
| 99457 E&M - Miscellaneous | Office | 62 | 14 | $42.72 | $2,649 |
| 99214 Office E&M - Established | Office | 53 | 44 | $104.08 | $5,516 |
| 99212 Office E&M - Established | Office | 40 | 39 | $39.91 | $1,596 |
| 99232 Hospital E&M - Subsequent | Facility | 29 | 20 | $64.63 | $1,874 |
| 43249 Upper GI Endoscopy | Facility | 15 | 14 | $111.20 | $1,668 |
By year: 2022 $159K for 2,234 services; 2023 $176K for 2,550 services; 2024 $190K for 3,085 services.
Medicare prescription drug claims, 2024
In 2024, the drug James J Lee prescribed most often to Medicare patients was Pantoprazole Sodium, with 534 prescriptions and refills. In total James J Lee wrote 3,488 Medicare prescriptions that cost $671K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 534 | 1,551 | 216 | $5,965 |
| Omeprazole Generic | 476 | 1,363 | 172 | $7,742 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 417 | 417 | 406 | $24K |
| Esomeprazole Magnesium Generic | 232 | 620 | 93 | $17K |
| Sucralfate Generic | 155 | 316 | 64 | $7,989 |
| Famotidine Generic | 149 | 413 | 58 | $2,445 |
| Dicyclomine Hcl Generic | 83 | 134 | 37 | $2,300 |
| Linzess Linaclotide | 80 | 116 | 25 | $61K |
| Hydrocortisone Generic | 70 | 75 | 50 | $1,435 |
| Metoclopramide Hcl Generic | 70 | 93 | 28 | $484 |
| Rabeprazole Sodium Generic | 59 | 137 | 18 | $2,042 |
| Cholestyramine Light Cholestyramine | 55 | 110 | 27 | $5,274 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 50 | 50 | Under 11 | $473 |
| Lansoprazole Generic | 49 | 111 | 16 | $1,726 |
| Dexlansoprazole Dr Dexlansoprazole | 48 | 109 | 12 | $15K |
Brand drugs: - claims; generic drugs: 3,026 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James J Lee $2,769 ($2,769 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $773.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 43 | $773 |
| Madrigal Pharmaceuticals MDGL | 17 | $459 |
| Ardelyx, Inc. ARDX | 12 | $297 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 13 | $257 |
| Aimmune Therapeutics, Inc. | 11 | $251 |
| Pfizer Inc. PFE | 7 | $138 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $118 |
| Genzyme Corporation SNY | 3 | $90.48 |
| Janssen Biotech, Inc. JNJ | 4 | $87.41 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $60.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.